One possible trouble spot: drug-coated Cypher stent. From Wordnik.com. [J&J Reports Results; Gain Forecast in PPI] Reference
Boston Scientific is the leading player in drug-coated stents. From Wordnik.com. [Boston Scientific Stent Wins Approval] Reference
An outside panel said the FDA should approve a Medtronic drug-coated stent. From Wordnik.com. [Medtronic's Endeavor Stent] Reference
The use of drug-coated stents has been studied in patients having heart attacks. From Wordnik.com. [Corrections & Amplifications] Reference
Weak sales spots continued to be J&J's anemia treatments and drug-coated stents. From Wordnik.com. [Yahoo's Progress] Reference
Akron Beacon Journal/Newscom Favorable studies have eased concerns about drug-coated stents. From Wordnik.com. [Study Might Ease Stent Fears] Reference
Medtronic is hoping the FDA will approve its proposed drug-coated stent by the end of this year. From Wordnik.com. [FDA Panel to Review Abbott Data] Reference
Last year's problems involved bulk supplies, vials of the medicine and drug-coated medical devices. From Wordnik.com. [Heparin Stirs New Fears] Reference
That business was helped by the recent U.S. introduction of Medtronic's "Endeavor" drug-coated stent. From Wordnik.com. [Medtronic to Cut 1,100 Jobs] Reference
Sales of surgical-care and joint-reconstruction products increased, but sales of drug-coated stents fell. From Wordnik.com. [J&J's Profit Falls 2.5% as Sales Slip] Reference
But they're saying for people who are at lower risk, then the drug-coated stents may be a good option there. From Wordnik.com. [CNN Transcript Mar 27, 2007] Reference
Boston Scientific has the most exposure to the market for drug-coated stents - and the most complex exposure. From Wordnik.com. [Boston Scientific's Net Loss Narrows] Reference
Sales of drug-coated stents have fallen off in the last several quarters because of worries about blood clots. From Wordnik.com. [Boston Scientific's Net Loss Narrows] Reference
Current guidelines call for patients who get a drug-coated stent to remain on the medicine for at least a year. From Wordnik.com. [Health Firms to Study Clots in Stent Patients] Reference
Boston Scientific Corp. 's third-quarter net loss narrowed despite continuing declines in drug-coated stent sales. From Wordnik.com. [Boston Scientific's Net Loss Narrows] Reference
The Texas case, filed in 2005, involved Boston Scientific's Taxus Express and Taxus Liberte stents, both drug-coated. From Wordnik.com. [Boston Scientific Loses Verdict] Reference
Abbott Laboratories posted a link in a YouTube video to the safety and risk information for its Xience V drug-coated stent. From Wordnik.com. [Corrections & Amplifications] Reference
Abbott said its Xience drug-coated stent gained the biggest market share in Japan following its February introduction there. From Wordnik.com. [Abbott Labs' Earnings, Outlook Hurt By Health Overhaul] Reference
Last week, Boston Scientific said its share in the U.S. market for drug-coated heart stents was steady in the third quarter. From Wordnik.com. [Boston Scientific's Net Loss Narrows] Reference
J&J said the recall doesn't affect Cordis's Cypher drug-coated cardiac stent, as the stent isn't delivered on these balloons. From Wordnik.com. [Johnson & Johnson Unit] Reference
Austrian researchers found that drug-coated heart stents may not increase the risk of blood clots as much as previously thought. From Wordnik.com. [CNN Transcript Sep 3, 2007] Reference
According to data from Abbott on Tuesday, its Xience drug-coated stent outperformed a blockbuster device from Boston Scientific. From Wordnik.com. [H-P Falls, EDS Rises] Reference
Abbotts Xience drug-coated stent, which hit the U.S. last summer, has quickly vaulted to a leading position in a rebounding market. From Wordnik.com. [Abbott Labs Posts 28% Rise in Net Income] Reference
At C Sixty, Sagman and his colleagues insert drug-coated fullerenes inside the virus that causes AIDS to prevent it from reproducing. From Wordnik.com. [Tiny Weapons With Giant Potential] Reference
Most of the clinical studies compared Xience to Boston Scientific Corp. 's Taxus drug-coated stent and involved about 1,000 patients. From Wordnik.com. [FDA Panel to Review Abbott Data] Reference
An FDA panel of experts begins a two-day session to decide whether to recommend approval of Medtronic's new drug-coated Endeavor stent. From Wordnik.com. [What's Ahead] Reference
He also said the recall doesn't affect Cordis's "Cypher" drug-coated stent heart device, as the stent isn't delivered on these balloons. From Wordnik.com. [Johnson & Johnson's Cordis Unit] Reference
That was attributed to falling prices and new competition from Medtronic Inc., which launched its own drug-coated stent earlier this year. From Wordnik.com. [Use of Coated Stents on the Rise] Reference
Abbott Laboratories received approval from China to sell its drug-coated Xience V stent, opening another market for the fast-growing product. From Wordnik.com. [Abbott Gets Chinese Clearance for Xience V Stent] Reference
Stents are small devices used to prop open previously clogged heart arteries, and drug-coated stents use medication to combat vessel renarrowing. From Wordnik.com. [Abbott Gets Chinese Clearance for Xience V Stent] Reference
Wall Street will continue to keep its eye on Abbott's new drug-coated stent, Xience V, which is expected to be approved in the U.S. during the second quarter. From Wordnik.com. [Abbott Posts Growth in All Sectors] Reference
Bruce Saffran, the plaintiff, sued in December 2005, alleging Boston Scientific's drug-coated stent system infringed a patent he owned that is valid until 2013. From Wordnik.com. [Judge Adds Interest To Patent Violation] Reference
LearnThatWord and the Open Dictionary of English are programs by LearnThat Foundation, a 501(c)3 nonprofit.
Questions? Feedback? We want to hear from you!
Email us
or click here for instant support.
Copyright © 2005 and after - LearnThat Foundation. Patents pending.

